EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
1.4.3.3 | additional information | mean DAAOactivity is 2fold higher in the schizophrenia patients group compared with the control group | Homo sapiens |
EC Number | Application | Comment | Organism |
---|---|---|---|
1.4.3.3 | medicine | D-serine availability in the nervous system may be altered in schizophrenia because of increased D-amino acid degradation by DAAO | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.4.3.3 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.4.3.3 | brain cortex | - |
Homo sapiens | - |
1.4.3.3 | cerebellum | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.4.3.3 | alanine + H2O + O2 | - |
Homo sapiens | pyruvate + NH3 + H2O2 | - |
? | |
1.4.3.3 | D-serine + H2O + O2 | - |
Homo sapiens | 2-oxo-3-hydroxypropionic acid + NH3 + H2O2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.4.3.3 | D-amino acid oxidase | - |
Homo sapiens |
1.4.3.3 | DAAO | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.4.3.3 | FAD | - |
Homo sapiens |